Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 oct. 2015 07h00 HE | Source: ABIOMED, Inc.

Abiomed Announces Q2 FY 2016 Revenue of $76.4 Million, Up 47% Over Prior Year

DANVERS, Mass., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2016 revenue of...
08 oct. 2015 08h20 HE | Source: ABIOMED, Inc.

Abiomed's Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions

DANVERS, Mass., Oct. 08, 2015 (GLOBE NEWSWIRE) -- Abiomed Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, announces that there are currently over 25...
08 oct. 2015 08h00 HE | Source: ABIOMED, Inc.

Abiomed to Appoint Seth Bilazarian, M.D., New Vice President of Interventional Cardiology Programs

DANVERS, Mass., Oct. 08, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Seth Bilazarian, M.D. will be...
08 oct. 2015 08h00 HE | Source: ABIOMED, Inc.

Abiomed Second Quarter Fiscal 2016 Earnings and Conference Call Notification

DANVERS, Mass., Oct. 08, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced today that on Thursday, October 29, 2015, the Company will release financial results for the second quarter...
10 sept. 2015 08h00 HE | Source: ABIOMED, Inc.

Abiomed to Present at the Morgan Stanley Global Healthcare Conference

DANVERS, Mass., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
17 août 2015 08h00 HE | Source: ABIOMED, Inc.

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0/LD Pre-Market Approval Supplements

DANVERS, Mass., Aug. 17, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, announced today that it has submitted U.S Food &...
11 août 2015 13h00 HE | Source: ABIOMED, Inc.

Abiomed Announces Corporate Partnership With Fenway Park; Brings Impella Mobile Learning Lab to Historic Stadium

DANVERS, Mass., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, announced today that it has entered into a corporate...
11 août 2015 08h00 HE | Source: ABIOMED, Inc.

Abiomed Outlines Long-Term Growth Strategy and Unveils Future Products at Annual Investor Conference

DANVERS, Mass., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, will present the Company’s long-term growth strategy...
05 août 2015 08h00 HE | Source: ABIOMED, Inc.

Abiomed to Hold Investor Day in Boston on August 11

DANVERS, Mass., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced today that the Company will webcast presentations at its Investor Day held in Boston, MA on Tuesday, August...
04 août 2015 07h00 HE | Source: ABIOMED, Inc.

Abiomed Announces Q1 FY 2016 Revenue of $73.4 Million, Up 50% Over Prior Year

DANVERS, Mass., Aug. 04, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2016 revenue of...

Page précédente